Living With Primary Ciliary Dyskinesia (Living With PCD)
1 other identifier
observational
1,500
1 country
1
Brief Summary
Living with PCD (formerly COVID-PCD) is a participatory research project that aims to answer emerging questions about primary ciliary dyskinesia (PCD) in order to improve the health and quality of life of people with PCD. Persons with confirmed or suspected PCD from anywhere in the world can participate. The study is advertised through patient support groups and participants register online after they read detailed information about the study. Participants receive a detailed questionnaire when they start the study and a follow-up questionnaire (planned once per year). Occasionally, participants receive extra questionnaires focused on special topics. The study is hosted at the University of Bern and recruitment started on May 30th, 2020.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2020
CompletedFirst Submitted
Initial submission to the registry
October 23, 2020
CompletedFirst Posted
Study publicly available on registry
October 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2030
December 2, 2025
November 1, 2025
10 years
October 23, 2020
November 26, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Patient-reported respiratory symptoms
Prevalence of reported clinical symptoms at different age groups such as cough, shortness of breath, hearing problems
At baseline and through study completion, an average of 1 year
Exercise-behaviour
Characteristics of exercise-behaviours (frequency, type) at baseline
At baseline and through study completion, an average of 1 year
Treatments
Information about prescribed treatments for PCD including antibiotics, inhalations, and physiotherapy
At baseline and through study completion, an average of 1 year
Eligibility Criteria
The study includes all persons with primary ciliary dyskinesia who can be contacted via patient organisation networks worldwide.
You may qualify if:
- People of any age with reported suspected or confirmed Primary Ciliary Dyskinesia who gave consent to participate in the study
You may not qualify if:
- People who report not to have suspected or confirmed Primary Ciliary Dyskinesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bernlead
- Selbsthilfegruppe Kartagener Syndrom und Primäre Ciliäre Dyskinesiecollaborator
- Verein Kartagener Syndrom und PCDcollaborator
- PCD Support UKcollaborator
- PCD Foundationcollaborator
- PCD Australiacollaborator
- European Lung Foundationcollaborator
- University of Southamptoncollaborator
- Universität Luzerncollaborator
- Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kargagener APScollaborator
- Asociación Nacional de Pacientes con Discinesia Ciliar Primariacollaborator
- Association Dyskinésie Ciliaire Primitive ADCPcollaborator
Study Sites (1)
Institute of Social and Preventive Medicine (ISPM), University of Bern
Bern, 3012, Switzerland
Related Publications (1)
Schreck LD, Pedersen ESL, Dexter K, Manion M; Living with PCD Study Advisory Group; Massin N, Maitre B, Goutaki M, Kuehni CE. Infertility and pregnancy outcomes among adults with primary ciliary dyskinesia. Hum Reprod Open. 2024 Jun 18;2024(3):hoae039. doi: 10.1093/hropen/hoae039. eCollection 2024.
PMID: 38962571DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia E Kuehni, Prof.
University of Bern
- STUDY DIRECTOR
Myrofora Goutaki, Prof
University of Bern
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2020
First Posted
October 26, 2020
Study Start
May 31, 2020
Primary Completion (Estimated)
May 31, 2030
Study Completion (Estimated)
May 31, 2030
Last Updated
December 2, 2025
Record last verified: 2025-11